Zobrazeno 1 - 10
of 23
pro vyhledávání: '"E A Klesareva"'
Autor:
N A Tmoyan, M V Ezhov, O I Afanasieva, E A Klesareva, O A Razova, V V Kukharchuk, S N Pokrovsky
Publikováno v:
Терапевтический архив, Vol 90, Iss 9, Pp 31-36 (2018)
Aim. Lipoprotein(a) [Lp(a)] is an independent risk factor of coronary heart disease (CHD) and myocardial infarction. Data about the role of Lp(a) in the development of peripheral artery disease (PAD) is controversial and uncertain. The aim of the stu
Externí odkaz:
https://doaj.org/article/571a6907198c4d418542a6f7288024b5
Autor:
O I Afanasievа, E A Pylaeva, E A Klesareva, A V Potekhina, S I Provatorov, M I Afanasieva, T L Krasnikova, V P Masenko, T I Arefieva, S N Pokrovsky
Publikováno v:
Терапевтический архив, Vol 88, Iss 9, Pp 31-38 (2016)
Aim. To study the role of lipoprotein(a) [Lp(a)] as a potential autoantigen causing the activation of immunocompetent cells in atherosclerosis. Subjects and methods. A total of 104 men with stable coronary artery (CA) disease and different degrees of
Externí odkaz:
https://doaj.org/article/c77ebc3f47e640ae93d6fe49b528ebe9
Autor:
A. Yu. Filatova, E. A. Larina, O. I. Afanasieva, L. N. Ilina, N. V. Radukhina, M. I. Afanasieva, E. A. Klesareva, A. A. Shiryaev, S. K. Kurbanov, E. E. Vlasova, V. P. Vasiliev, Sergey N. Pokrovsky, Tatiana I. Arefieva
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 11 (2023)
Aim. To assess the level of lipoprotein (a) (Lp(a)) and other lipid profile parameters, the composition of blood leukocytes in patients with focal and diffuse coronary atherosclerosis who underwent coronary artery bypass surgery (CABG), as well as to
Externí odkaz:
https://doaj.org/article/fbaf57ba306e4d07bbd2e68ef7985da5
Autor:
U. V. Chubykina, M. V. Ezhov, O. I. Afanas’eva, E. A. Klesareva, N. A. Tmoyan, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 6 (2022)
Aim. To evaluate the prevalence of familial hypercholesterolemia (FH) and hyperlipoproteinemia(a) (HLP(a)) in patients with premature acute coronary syndrome (ACS).Material and methods. The study included 120 patients with ACS up to 60 years (mean ag
Externí odkaz:
https://doaj.org/article/a35ca7d9a8c7452faf67c2cc21c45774
Autor:
A. V. Tyurina, O. I. Afanas’eva, E. A. Klesareva, N. A. Tmoyan, O. A. Razova, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 6 (2022)
Aim. To assess the relationship between premature coronary artery disease (CAD) and various lipid parameters.Material and methods. This retrospective longitudinal study included 166 men aged 57±9 years with coronary CAD with onset before age of 55.
Externí odkaz:
https://doaj.org/article/07ddb3049dcb47e1a9601d56b8d86d3a
Autor:
A. Yu. Filatova, O. I. Afanasieva, T. I. Arefieva, E. A. Klesareva, A. V. Tyurina, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 6 (2022)
Aim. To analyze the relationship of blood lipid profile parameters, including the level of lipoprotein(a) (Lp(a)), and the content of circulating CD4+ T-lymphocytes with premature coronary artery disease (CAD).Material and methods. This retrospective
Externí odkaz:
https://doaj.org/article/fb81eab07c2543e0ad6b10afc15b7d60
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 52-55 (2019)
Statins are currently the main group of lipid-lowering drugs used in clinical practice. However not all patients manage to achieve ‘target’ levels of LDL. A possible cause is statin-induced increase of expression of hepatocyte PCSK9 which regulat
Externí odkaz:
https://doaj.org/article/27a538ed541d470389d43122911aea0c
Autor:
A. L. Burdeynaya, O. I. Afanasyeva, E. A. Klesareva, N. A. Tmoyan, O. A. Razova, M. I. Afanasyeva, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 2 (2021)
Aim. To study the relationship between the concentration of lipoprotein (a) (Lp (a)) and autotaxin (ATX) in patients with and without degenerative aortic valve stenosis (AoS) in the presence of coronary artery disease (CAD).Material and methods. The
Externí odkaz:
https://doaj.org/article/cdab7e24474445198c80c3865095a0df
Autor:
E. A. Klesareva, O. I. Afanasieva, E. V. Kononova, E. A. Utkina, M. V. Ezhov, T. V. Balakhonova, M. I. Afanasieva, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 13-20 (2018)
Aim. To investigate on the relation of lipoproteide(a) (Lpa), subfractions of atherogenic lipoproteides and titers of specific autoantibodies (autoAb) with the presence and severity of carotid arteries (CA) lesion in statin-naïve patients with sever
Externí odkaz:
https://doaj.org/article/6339af9e45814c28a21cc00945ff86f8
Autor:
N. A. Tmojan, О I. Afanasieva, A. Е. Zotikov, E. A. Klesareva, M. M. Abdulgamidov, М. V. Ezhov, A. V. Pokrovsky, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 7-12 (2018)
Aim. Lipoproteide (a) (Lpa) is a pathogenetic risk factor of cardiovascular atherosclerotic disease. On the role of Lpa in the development of cardiovascular complications (CVC) after lower limbs arteries revascularization, there is lack of data. The
Externí odkaz:
https://doaj.org/article/a92f82a2d7cf48e4ae016058842fdb12